Please login to the form below

Not currently logged in
Email:
Password:

tocilizumab

This page shows the latest tocilizumab news and features for those working in and with pharma, biotech and healthcare.

Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses

Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses

Roche’s existing rheumatoid arthritis drug Actemra (tocilizumab) is also being studied in combination with Gilead’s antiviral remdesivir in hospitalised patients with severe COVID-19 pneumonia in the REMDACTA trial.

Latest news

More from news
Approximately 7 fully matching, plus 58 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...

Infographics